BackSummit Therapeutics Overview

Summit Therapeutics Target Price

Analysts' 12-month price predictions for SMMT.

Share Price


Average Target Price

$11.0041% upside

2 analysts in the last 4 months

High: $14 | Low: $8

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2024-06-03Stifel NicolausBrad Canino$1479.5% upsideOpen
2024-03-25Stifel NicolausBrad Canino$82.6% upsideOpen